As per the UKHSA Annual epidemiological commentary1, nationally, Clostridioides difficile infection (CDI) cases have increased from 2020 to 2024 by 33%; this marks the highest overall case rate since 2011 both healthcare associated and community associated CDI cases. CDI cases are considered hospital-onset if they occur 4 or more days after admission to an acute trust (HOHA), or admitted to the reporting organization within the past 12 weeks (COHA), all others are categorised as community associated (COCA or COIA) as per UKHSA categorisation.
Overall, community cases have seen a 21% increase from 2021-2024 and have always shown a peak in the second quarter of the financial year (Jul-Sep). Community-onset cases now constitute the greater burden of all CDI for 2023/24, 59.9%. We are seeing a higher proportion of female cases than males across all age groups except in the aged 85 years, and a significant increase in females aged 15 to 44 years.
UKHSA data from the past 4 years show no significant changes in C. difficile ribotypes. Current hypothesis for the increase, suggest challenges in infection prevention during the pandemic, changes in antibiotic use, and improved CDI detection may be contributing factors.
Historically1, CDI was primarily an issue within the hospital setting with around 60.2% of infections defined as hospital-onset. Many of the interventions aimed at the reduction of CDI rates were targeted at the hospital setting, and as a result the sharp decline that has been observed has disproportionately affected hospital-onset infections compared to community-onset infections. Consequently, community-onset cases now constitute the greater burden of all CDI for the reporting period (59.9%).
In Buckinghamshire Oxfordshire and Berkshire West Integrated Care System (BOB ICS), CDI increased year on year until 2023/24 when a total reduction from 405 to 398 was seen, although, community onset cases, continue to increase from 179 to 193, as seen in figure 1. The BOB Integrated Care Board (ICB) Infection Prevention & Control (IP&C) team investigate all community onset CDI cases, whilst the acute trusts review the healthcare categorised cases.
Previously, as the IP&C team do not have access to patient records, an email was sent to GP’s with a request to complete a ‘Post infection review’ form and the prior prescribing was reviewed against prescribing guidelines, but response was poor, and it was a challenge to understand the risk factors in order to suggest ways to reduce community CDI. Therefore, a pilot was trialled in March and April 2024 to gather this information from GP’s on each case using a less time consuming process, that would collate data and provide presentation graphs to support the findings. Changes and updates were made on the feedback, and the Community onset C.difficile analysis 2024/25 was launched on 1st April 2024.
Set up and MS Forms link. Suggested questions attached.
ICB – Setting up a dataset for your area (can be by non-clinical administration).
Providing reports
Log on to MS Forms
Click on responses (top left corner), download a copy in excel Remember to date/ID spreadsheet, as responses will continue to be submitted), select appropriate graphs required and add context from the responses. Check and share your form results.
Email template used to send to GP’s
Dear Name of GP practice
Please forward to the patients’ GP.
Dear Doctor
Your patient (AB), NHS No 000-000-0000, DOB 00/00/1900, tested positive for C.difficile infection (CDI) on 01/01/2001. Please copy the ID <insert local ID>, and paste into the <insert local MS Forms page link> to complete the investigation into this community onset GP CDI sample.
We appreciate that this patient may not have had contact with primary care recently, but we would appreciate your feedback in order to understand risk factors and reduce CDI categorised as community onset.
This data gathering process is designed to be less time consuming for GP’s, it supports the delivery of Regulation 12: Safe Care and treatment (CQC) and Criteria 1 of the Code of Practice. Any learning from analysis of CDI cases should be included in the practices Annual Infection and Prevention Control Statement. An anonymised report of all GP CDI samples will be presented at the ICB quarterly Infection Prevention Control Committee and is available on request.
On completion of the form, please submit and click on the 3 dots in the top right-hand corner, click on print and from the drop down, save as a PDF for your records.
Please email <insert local email address>if you have queries about this form or would like to provide feedback. We would value your comments on how the form can be improved.
Kind regards
Suggestions
Further any further information please contact Hilary Munube bobicb.ipc@nhs.net
References
Further Reading